This announcement is a separate document:
大洋生物：上海市锦天城律师事务所关于浙江大洋生物科技集团股份有限公司2023年年度股东大会法律意见书
Zhejiang Dayang Biotech Group: Legal Opinion of Shanghai AllBright Law Firm on the 2023 Annual General Meeting of Shareholders of Zhejiang Dayang Biotechnology Group Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated